NO20002828D0 - Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav - Google Patents

Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav

Info

Publication number
NO20002828D0
NO20002828D0 NO20002828A NO20002828A NO20002828D0 NO 20002828 D0 NO20002828 D0 NO 20002828D0 NO 20002828 A NO20002828 A NO 20002828A NO 20002828 A NO20002828 A NO 20002828A NO 20002828 D0 NO20002828 D0 NO 20002828D0
Authority
NO
Norway
Prior art keywords
serogroup
preparation
vaccine against
against neisseria
proteinaceous vaccine
Prior art date
Application number
NO20002828A
Other languages
English (en)
Original Assignee
Statens Inst For Folkehelse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19911219&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002828(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Statens Inst For Folkehelse filed Critical Statens Inst For Folkehelse
Priority to NO20002828A priority Critical patent/NO20002828D0/no
Publication of NO20002828D0 publication Critical patent/NO20002828D0/no
Priority to APAP/P/2002/002681A priority patent/AP1690A/en
Priority to AU2001264427A priority patent/AU2001264427A1/en
Priority to US10/296,212 priority patent/US20040131642A1/en
Priority to AT01938851T priority patent/ATE345143T1/de
Priority to PCT/NO2001/000232 priority patent/WO2001091788A1/en
Priority to CA002410652A priority patent/CA2410652A1/en
Priority to EP01938851A priority patent/EP1286696B1/en
Priority to OA1200200362A priority patent/OA12278A/en
Priority to DE60124538T priority patent/DE60124538D1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NO20002828A 2000-06-02 2000-06-02 Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav NO20002828D0 (no)

Priority Applications (10)

Application Number Priority Date Filing Date Title
NO20002828A NO20002828D0 (no) 2000-06-02 2000-06-02 Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
DE60124538T DE60124538D1 (de) 2000-06-02 2001-06-05 Impfstoff umfassend aussenmembranvesikel gegen krankheiten verursacht durch i neisseria meningitidis/i serogruppe a und verfahren zur herstellung desselben
OA1200200362A OA12278A (en) 2000-06-02 2001-06-05 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup A and process for the production thereof.
US10/296,212 US20040131642A1 (en) 2000-06-02 2001-06-05 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof
AU2001264427A AU2001264427A1 (en) 2000-06-02 2001-06-05 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof
APAP/P/2002/002681A AP1690A (en) 2000-06-02 2001-06-05 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup A and process for the production thereof.
AT01938851T ATE345143T1 (de) 2000-06-02 2001-06-05 Impfstoff umfassend aussenmembranvesikel gegen krankheiten verursacht durch i neisseria meningitidis/i serogruppe a und verfahren zur herstellung desselben
PCT/NO2001/000232 WO2001091788A1 (en) 2000-06-02 2001-06-05 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof
CA002410652A CA2410652A1 (en) 2000-06-02 2001-06-05 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof
EP01938851A EP1286696B1 (en) 2000-06-02 2001-06-05 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20002828A NO20002828D0 (no) 2000-06-02 2000-06-02 Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav

Publications (1)

Publication Number Publication Date
NO20002828D0 true NO20002828D0 (no) 2000-06-02

Family

ID=19911219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002828A NO20002828D0 (no) 2000-06-02 2000-06-02 Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav

Country Status (10)

Country Link
US (1) US20040131642A1 (no)
EP (1) EP1286696B1 (no)
AP (1) AP1690A (no)
AT (1) ATE345143T1 (no)
AU (1) AU2001264427A1 (no)
CA (1) CA2410652A1 (no)
DE (1) DE60124538D1 (no)
NO (1) NO20002828D0 (no)
OA (1) OA12278A (no)
WO (1) WO2001091788A1 (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783894B2 (en) 1999-05-19 2005-12-22 Novartis Vaccines And Diagnostics S.R.L. Combination neisserial compositions
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
KR20030024811A (ko) 2000-07-27 2003-03-26 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신
GB0130123D0 (en) 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
WO2004046177A2 (en) 2002-11-15 2004-06-03 Chiron Srl Unexpected surface proteins in neisseria meningitidis
CU23313A1 (es) * 2002-11-27 2008-09-25 Inst Finlay Ct De Investigacia Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
WO2004054611A1 (en) * 2002-12-16 2004-07-01 Nasjonalt Folkehelseinstitutt Meningococcal vaccine based on outer membrane proteins porb2 and pora
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
CU23377A1 (es) * 2003-11-04 2009-05-28 Ct De Ingenieria Genetica Y Biotecnologia Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes
GB0416120D0 (en) 2004-07-19 2004-08-18 Health Prot Agency Stable compositions containing OMV's
GB0419627D0 (en) 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
LT2682126T (lt) 2005-01-27 2017-02-27 Children`s Hospital & Research Center at Oakland Gna1870 pagrindu gaminamos pūslelių pavidalo vakcinos, skirtos plataus spektro apsaugai nuo neisseria meningitidis sukeltų ligų
ATE496987T1 (de) 2006-05-22 2011-02-15 Biovest Int Inc Ausserkapilläres fluidzirkulationssystem und - verfahren
BR122016015627A2 (pt) 2007-10-19 2018-10-30 Novartis Ag kit, composição antigênica liofilizada e método para preparação de uma composição imunogênica
EP2886551A3 (en) 2008-02-21 2015-09-23 Novartis AG Meningococcal fhbp polypeptides
ES2546213T3 (es) 2008-03-03 2015-09-21 Novartis Ag Compuestos y composiciones como moduladores de la actividad de TLR
RU2477145C2 (ru) * 2008-05-30 2013-03-10 ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
WO2010070453A2 (en) 2008-12-17 2010-06-24 Novartis Ag Meningococcal vaccines including hemoglobin receptor
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
US8858958B2 (en) 2009-08-27 2014-10-14 Novartis Ag Adjuvant comprising aluminum, oligonucleotide and polycation
JP2013502918A (ja) 2009-08-27 2013-01-31 ノバルティス アーゲー 髄膜炎菌ｆＨＢＰ配列を含むハイブリッドポリペプチド
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
US20130022639A1 (en) 2009-09-30 2013-01-24 Novartis Ag Expression of meningococcal fhbp polypeptides
BR112012010531A2 (pt) 2009-10-27 2019-09-24 Novartis Ag "polipeptídeos de modificação meningocócica fhbp"
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
WO2012020326A1 (en) 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
BR112013005626B1 (pt) 2010-09-10 2022-07-26 Glaxosmithkline Biologicals Sa Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição
US20150147356A1 (en) 2011-05-12 2015-05-28 Alan Kimura Antipyretics to enhance tolerability of vesicle-based vaccines
WO2012171030A2 (en) * 2011-06-10 2012-12-13 Biovest International, Inc. Method and apparatus for antibody production and purification
MX2014008988A (es) 2012-02-02 2014-08-27 Novartis Ag Promotores para aumento de expresion de proteinas en meningococo.
ES2750366T3 (es) 2012-03-08 2020-03-25 Glaxosmithkline Biologicals Sa Ensayo de potencia in vitro para vacunas meningocócicas basadas en proteína
MX357538B (es) 2012-06-14 2018-07-13 Novartis Ag Vacunas para meningococo de serogrupo x.
EP2909302A4 (en) 2012-08-28 2016-07-27 Biovest Int Inc BIOFABRICATION FILAMENT AND METHOD FOR LARGE-SCALE PRODUCTION OF CELLS, VIRUSES AND BIOMOLECULES
EP2892553A1 (en) 2012-09-06 2015-07-15 Novartis AG Combination vaccines with serogroup b meningococcus and d/t/p
RU2662970C2 (ru) 2012-09-18 2018-07-31 Новартис Аг Везикулы наружной мембраны
US20160120818A1 (en) 2013-02-07 2016-05-05 Glaxosmithline Biological Sa Pharmaceutical compositions comprising vesicles
CA2940447C (en) 2014-02-28 2023-07-11 Glaxosmithkline Biologicals Sa Modified meningococcal fhbp polypeptides
EP3298031B1 (en) 2015-05-18 2020-10-21 BiOMVis Srl Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof
WO2018042015A1 (en) 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
US12128094B2 (en) 2018-11-06 2024-10-29 Glaxosmithkline Biologicals Sa Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a tetanus toxoid and a diphtheria toxoid
CN112410239B (zh) * 2019-08-22 2023-03-24 四川大学 细菌膜囊泡及其制备方法与应用
TW202602458A (zh) 2024-02-16 2026-01-16 美商賽諾菲巴斯德公司 用於製備去氧膽酸之方法
WO2025183190A1 (ja) * 2024-02-28 2025-09-04 株式会社ヤクルト本社 グラム陽性菌の膜小胞の製造方法及びその膜小胞の利用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0630260B1 (en) * 1991-03-12 2001-01-24 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Polysaccharide-protein conjugates
US5324442A (en) * 1992-06-16 1994-06-28 Kansas State University Research Foundation Fermentation process for the production of calcium magnesium road deicer
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
WO1999036544A2 (en) * 1998-01-14 1999-07-22 Chiron S.P.A. Neisseria meningitidis antigens
GB9820003D0 (en) * 1998-09-14 1998-11-04 Smithkline Beecham Biolog Novel compounds
AU2107400A (en) * 1999-01-15 2000-08-01 Smithkline Beecham Biologicals (Sa) Neisseria meningitidis antigen
AU756832B2 (en) * 1999-02-22 2003-01-23 Ncsrt, Inc. Purification of biological substances
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
KR20030024811A (ko) * 2000-07-27 2003-03-26 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0024200D0 (en) * 2000-10-03 2000-11-15 Smithkline Beecham Sa Component vaccine

Also Published As

Publication number Publication date
AP2002002681A0 (en) 2002-12-31
EP1286696A1 (en) 2003-03-05
OA12278A (en) 2006-05-11
AP1690A (en) 2006-12-11
DE60124538D1 (de) 2006-12-28
US20040131642A1 (en) 2004-07-08
AU2001264427A1 (en) 2001-12-11
CA2410652A1 (en) 2001-12-06
ATE345143T1 (de) 2006-12-15
EP1286696B1 (en) 2006-11-15
WO2001091788A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
FR22C1001I1 (fr) Vaccin conjugué de protéine et de polysaccharide pour méningococcie polyvalente
IL174983A0 (en) Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein
DK1228217T3 (da) Konserverede neisseria-antigener
CY2009014I2 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
NO20031483L (no) Vaksine
NO20031274D0 (no) Anvendelse av immidazokinolinaminer som adjuvanser i DNA- vaksinasjon
NO20024172L (no) Vaksine
CY2011001I2 (el) Εμβολια συνδυασμου για neisseria meningitidis
DE60118440D1 (de) Start- und antriebsstrangstossschutz-steuerverfahren und -system
AU2001271963A1 (en) Mid-life vaccine and methods for boosting anti-mycobacterial immunity
CY2006004I1 (el) Μεθοδος διαχωρισμου παραλλαγων ροταϊου και ζωντανο εξασθενημενο εμβολιο ροταϊου
EP1307130A4 (en) VACCINE AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY
EP1423141A4 (en) VACCINE
NO20025158D0 (no) Lipidpreparat og anvendelse derav
EP1369101A4 (en) COSMETIC W / Ö / W EMULSION PREPARATION
NO20011193D0 (no) Vaksine mot seksuelt overførbare sykdommer
NO20034413L (no) Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst
DK1281616T3 (da) Væskepåfyldningsmetode
DE60131348D1 (de) Geräteerkennungssystem und -verfahren
AU2001269640A1 (en) Vaccine against the influenza virus and method for producing said virus vaccine
AU6964001A (en) Vaccine against the influenza virus and method for producing said virus vaccine
FI20002329L (fi) Pakettikytkennäinen äänitysmenetelmä ja laite
FI20000893L (fi) Akustinen puhdistuslaite ja -menetelmä
DE60140982D1 (de) Polierverfahren und Vorrichtung
FI20002780L (fi) Sähkömekaaninen muunnin ja menetelmä sähkömekaanisen muuntimen valmistamiseksi